Evidence map›Paper›PMID 35696755›Full record

ArticleSleep medicine2022

The association between sleep disturbances and neurocognitive function in pediatric sickle cell disease.

Tiffany Tucker, Ammar Saadoon Alishlash, Jeffrey D Lebensburger, Olivio J Clay, Gabriela R Oates, Anis Nourani, Smita Bhatia, Donna L Murdaugh

Open access · greenAbstract read
In one paragraph

Article in Sleep medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multicenter comparative study of polysomnography outcomes in children with the monogenic disorder sickle cell disease.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tiffany TuckerDepartment of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA.
Ammar Saadoon AlishlashDepartment of Pediatrics, Division of Pediatric Pulmonary & Sleep Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Jeffrey D LebensburgerDepartment of Pediatrics, Division of Hematology/Oncology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Olivio J ClayDepartment of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA.
Gabriela R OatesDepartment of Pediatrics, Division of Pediatric Pulmonary & Sleep Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Anis NouraniDepartment of Pediatrics, Division of Pediatric Pulmonary & Sleep Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Smita BhatiaDepartment of Pediatrics, Division of Hematology/Oncology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute of Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.
Donna L MurdaughDepartment of Pediatrics, Division of Hematology/Oncology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute of Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: donnamurdaugh@uabmc.edu.
University of Alabama at Birmingham · US

Funding

UAB Health Services Research (HSR) Training ProgramT32HS013852 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEVITAN, EMILY B, MUGAVERO, MICHAEL J · 2003 to 2024
$8.0M
AHRQ HHS T32 HS013852
6 · The paper itself

Abstract

BACKGROUND AND

objectiveYouth with sickle cell disease (SCD) without neurological complications continue to be at increased risk of neurocognitive difficulties. Nocturnal hypoxemia is associated with neurocognitive outcomes and has been identified as a chronic complication in youth with SCD. The objective of this study was to assess the relationship between sleep disturbances and neurocognitive functioning in youth with SCD, while taking into account demographic and socioeconomic factors.

methodsYouth with SCD were identified through retrospective chart review who underwent a standardized polysomnography (PSG) and completed a neuropsychological testing battery to assess cognitive skills, including verbal comprehension, working memory, processing speed, and cognitive flexibility. Questionnaires were also collected to assess parent-reported concerns with their youth's executive and adaptive skills.

resultsTwenty-seven youth with SCD, ages 6-17, were identified who completed both a PSG and neuropsychological testing. Results demonstrated that verbal comprehension decreased by 2.37 standard points for every unit decrease in mean nocturnal oxygen saturation (SpO2) (p = 0.031). Working memory was also found to decrease by 1.46 standard points for each 1% increase in time spent under 90% oxygen saturation (pTST SpO2 < 90%) (p = 0.030). Sleep parameters did not significantly predict other cognitive scores or parent-reported executive or behavioral ratings.

conclusionOur study found that sleep disturbance, mean nocturnal SpO2 and pTST SpO2 < 90%, significantly affected verbal comprehension and working memory performance, respectively. Overall, these findings have the potential to identify sleep needs in youth with SCD to promote sleep-targeted interventions as a modifiable factor to reduce neurocognitive deficits.

Indexed as

Anemia, Sickle CellSleep Wake DisordersAdolescentChildExecutive FunctionHumansPolysomnographyRetrospective StudiesSleepNeuropsychologyNocturnalPolysomnographySickle cell diseaseSocioeconomic statusYouth

Identifiers

PMID35696755
PMCPMC9623971
OpenAlexW4281561353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.